Your browser is no longer supported. Please, upgrade your browser.
Settings
NVCN Neovasc Inc. daily Stock Chart
NVCN [NASD]
Neovasc Inc.
Index- P/E- EPS (ttm)-0.28 Insider Own3.24% Shs Outstand78.92M Perf Week44.69%
Market Cap3.55M Forward P/E- EPS next Y-0.13 Insider Trans0.00% Shs Float- Perf Month-3.23%
Income- PEG- EPS next Q-0.05 Inst Own3.60% Short Float- Perf Quarter-80.43%
Sales5.39M P/S0.66 EPS this Y79.70% Inst Trans- Short Ratio0.78 Perf Half Y-94.67%
Book/sh-0.35 P/B- EPS next Y50.00% ROA- Target Price1.88 Perf Year-97.00%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range0.03 - 1.89 Perf YTD-92.50%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-97.62% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low59.01% ATR0.01
Employees110 Current Ratio- Sales Q/Q-55.50% Oper. Margin- RSI (14)45.66 Volatility11.83% 14.27%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.65 Prev Close0.04
ShortableYes LT Debt/Eq- EarningsMay 10 AMC Payout- Avg Volume94.89M Price0.05
Recom1.00 SMA2012.26% SMA50-26.26% SMA200-93.48% Volume156,235,941 Change12.22%
Jan-19-18Resumed Canaccord Genuity Buy $1.05
Apr-05-17Upgrade Ladenburg Thalmann Neutral → Buy
May-20-16Downgrade Ladenburg Thalmann Buy → Neutral
Dec-10-15Initiated Ladenburg Thalmann Buy $9.25
Oct-07-15Resumed JMP Securities Mkt Outperform
Apr-02-15Initiated Canaccord Genuity Buy $15
Mar-31-15Initiated Northland Capital Outperform $12
May-15-18 07:30AM  Neovasc's Management and Board of Directors Urge Shareholders to Vote In Favor of the Proposed Reverse Stock Split at the Upcoming Annual General and Special Meeting of Shareholders CNW Group -9.07%
May-11-18 08:10AM  Todays Research Reports on Stocks to Watch: Puma Biotechnology and Neovasc ACCESSWIRE -18.54%
05:06AM  Neovasc: 1Q Earnings Snapshot Associated Press
May-10-18 04:05PM  Neovasc Announces Results for the First Quarter 2018 CNW Group
02:00PM  Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule CNW Group
Apr-30-18 05:26PM  Neovasc Provides a General Update, Announces Filing of Annual Report on Form 20-F and Sets First Quarter 2018 Financial Results Conference Call and Webcast CNW Group
08:20AM  Today's Research Reports on Trending Tickers: Neovasc and Puma Biotechnology ACCESSWIRE
Apr-19-18 07:10AM  Blog Exposure - NovoCure Announced Positive Top-line Results from STELLAR Trial Assessing TTFields in Mesothelioma ACCESSWIRE -5.51%
Apr-11-18 04:30PM  Neovasc Announces Receipt of US$7.1 Million from Exercise of Series C Warrants CNW Group
08:31AM  What Should We Expect From Neovasc Incs (NASDAQ:NVCN) Earnings In The Years Ahead? Simply Wall St.
Apr-06-18 08:20AM  Todays Research Reports on Trending Tickers: AVEO Pharmaceuticals and Neovasc ACCESSWIRE +48.66%
Apr-01-18 07:19AM  Was Neovasc Incs (NASDAQ:NVCN) Earnings Growth Better Than The Industrys? Simply Wall St.
Mar-28-18 04:00PM  Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2017 PR Newswire +7.14%
04:00PM  Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2017 CNW Group
12:30PM  Neovasc Inc. to Host Earnings Call ACCESSWIRE
Mar-23-18 04:30PM  Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency PR Newswire
Mar-21-18 04:30PM  Neovasc Announces Year End 2017 Financial Results Conference Call and Webcast PR Newswire
04:30PM  Neovasc Announces Year End 2017 Financial Results Conference Call and Webcast CNW Group
Mar-16-18 06:46AM  Is Neovasc Inc (NASDAQ:NVCN) A Buy At Its Current PE Ratio? Simply Wall St. +20.25%
Mar-13-18 08:10AM  Neovasc, Pipeline Development, Analysts Target Price, Institutional Investors ACCESSWIRE -17.67%
Feb-28-18 08:02AM  TSX Companies Insiders Are Buying Simply Wall St. +26.21%
Feb-12-18 07:00AM  Neovasc to Present at LEERINK Partners 7th Annual Global Healthcare Conference CNW Group
Feb-01-18 07:00AM  Neovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer Procedure for Treatment of Refractory Angina PR Newswire
07:00AM  Neovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer Procedure for Treatment of Refractory Angina CNW Group
Jan-22-18 07:00AM  Fred Colen Appointed Chief Executive Officer of Neovasc Inc. PR Newswire +23.34%
07:00AM  Fred Colen Appointed Chief Executive Officer of Neovasc Inc. CNW Group
Jan-18-18 07:00AM  Neovasc Reducer Featured in Live Case at Berlin Symposium PR Newswire
Jan-08-18 07:00AM  Neovasc Reports Tiara's Clinical Case Load Accelerating PR Newswire
07:00AM  Neovasc Reports Tiara's Clinical Case Load Accelerating CNW Group
Jan-02-18 05:00PM  Neovasc Receives NASDAQ Notification Regarding Minimum Bid Requirements CNW Group
Dec-06-17 07:00AM  Neovasc Reducer Featured in Live Case at ICI 2017 CNW Group
Nov-29-17 07:59AM  Neovasc, Inc. :NVCN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017 Capital Cube
Nov-27-17 10:27AM  Neovasc to Present at the Piper Jaffray 29th Annual Healthcare Conference PR Newswire
10:27AM  Neovasc to Present at the Piper Jaffray 29th Annual Healthcare Conference CNW Group
Nov-17-17 10:02AM  Neovasc Closes Offering of Units Consisting of Common Shares and Warrants and Concurrent Private Placement of Notes and Warrants CNW Group +8.94%
Nov-16-17 09:33AM  At $0.99, Is Neovasc Inc (TSX:NVCN) A Buy? Simply Wall St.
05:14AM  Neovasc reports 3Q loss Associated Press
Nov-14-17 04:00PM  Neovasc Announces Results for the Third Quarter of 2017 PR Newswire -16.83%
04:00PM  Neovasc Announces Results for the Third Quarter of 2017 CNW Group
Nov-10-17 02:56PM  Neovasc to Host Third Quarter 2017 Conference Call PR Newswire -28.08%
02:56PM  Neovasc to Host Third Quarter 2017 Conference Call CNW Group
01:15AM  Neovasc Announces US$65 Million Underwritten Offering of Units Consisting of Common Shares and Warrants To Purchase Common Shares and Concurrent Private Placement of Notes and Warrants PR Newswire
Nov-06-17 07:00AM  Neovasc Receives FDA Approval to Initiate Pivotal Reducer Trial CNW Group +13.74%
Nov-03-17 02:44PM  Neovasc Provides Litigation Update PR Newswire -5.76%
02:44PM  Neovasc Provides Litigation Update CNW Group
Nov-02-17 09:56AM  What You Must Know About Neovasc Incs (TSX:NVCN) Major Investors Simply Wall St.
Oct-04-17 08:04AM  Dilution Ahead For Neovasc Inc (TSX:NVCN) Shareholders? Simply Wall St.
Sep-15-17 11:13AM  Why You Need To Look At This Factor Before Buying Neovasc Inc (TSX:NVCN) Simply Wall St.
Sep-12-17 07:00AM  Neovasc Provides Tiara Clinical Update CNW Group +6.90%
Sep-05-17 07:00AM  Neovasc's Reducer System Reviewed in European Heart Journal CNW Group +12.28%
Sep-01-17 12:26PM  Decision from Appeals Court upholds lower court decisions but denies injunction PR Newswire +44.30%
12:26PM  Decision from Appeals Court upholds lower court decisions but denies injunction CNW Group
10:08AM  IIROC Trade Halt - Neovasc Inc. Newsfile
Aug-25-17 10:46AM  Neovasc, Inc. :NVCN-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017 Capital Cube
Aug-10-17 09:55PM  Neovasc reports 2Q loss Associated Press
04:00PM  Neovasc Announces Results for the Second Quarter of 2017 CNW Group
Aug-03-17 01:28PM  Neovasc to Host Second Quarter 2017 Conference Call CNW Group
Jun-26-17 10:38AM  Edwards Lifesciences Wins a Patent Case against Neovasc Market Realist
Jun-16-17 10:44AM  Neovasc Announces German Court Ruling PR Newswire -6.91%
Jun-15-17 07:00AM  Neovasc Tiara Featured in TVT 2017 Presentation PR Newswire
07:00AM  Neovasc Tiara Featured in TVT 2017 Presentation CNW Group
Jun-13-17 04:30PM  Neovasc Inc. Reports Results of Annual General Meeting of Shareholders PR Newswire +5.44%
04:30PM  Neovasc Inc. Reports Results of Annual General Meeting of Shareholders CNW Group
Jun-12-17 07:00AM  Neovasc to Present at JMP Securities Life Sciences Conference PR Newswire
07:00AM  Neovasc to Present at JMP Securities Life Sciences Conference CNW Group
Jun-02-17 10:21AM  Neovasc, Inc. :NVCN-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017 Capital Cube
May-10-17 04:16PM  Neovasc reports 1Q loss Associated Press
04:00PM  Neovasc Announces Results for the First Quarter of 2017 CNW Group
10:00AM  Investor Network: Neovasc Inc. to Host Earnings Call Accesswire
May-09-17 09:24AM  DENTSPLY (XRAY) Earnings and Revenues Miss Estimates in Q1 Zacks +6.29%
09:10AM  Integer (ITGR) Q1 Earnings Miss, Revenues Beat Estimates Zacks
May-08-17 09:31AM  Abiomed (ABMD) Q4 Earnings Meet, Revenues Beat Estimates Zacks +5.30%
May-05-17 10:03AM  Allscripts (MDRX) Beats on Q1 Earnings, Revenues In Line Zacks
08:21AM  Wright Medical (WMGI) Posts Wider-than-Expected Loss in Q1 Zacks
08:19AM  PerkinElmer (PKI) Tops Q1 Earnings Estimates, FY17 View Up Zacks
May-04-17 10:42AM  athenahealth (ATHN) Earnings, Revenues Miss Estimates in Q1 Zacks
09:00AM  AmerisourceBergen (ABC) Beats on Q2 Earnings, Lags Revenues Zacks
May-03-17 10:00AM  DaVita (DVA) Earnings Miss Estimates, Revenues Beat in Q1 Zacks
08:41AM  DexCom (DXCM) Q1 Loss Narrower than Expected, Revenues Miss Zacks
May-02-17 10:35AM  Ecolab (ECL) Q1 Earnings Miss Estimates, Revenues In Line Zacks
10:09AM  Becton, Dickinson (BDX) Q2 Earnings Beat, Increase Y/Y Zacks
May-01-17 09:00AM  Neovasc to Host First Quarter 2017 Conference Call PR Newswire
Apr-06-17 09:26AM  Will Neovasc (NVCN) Continue to Surge Higher? Zacks
Mar-29-17 01:04PM  NEOVASC INC Financials
Mar-27-17 08:32AM  Neovasc, Inc. :NVCN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 27, 2017 Capital Cube -5.92%
Mar-23-17 04:21PM  Neovasc posts 4Q profit Associated Press
04:00PM  Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2016 PR Newswire
04:00PM  Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2016 CNW Group
Mar-15-17 08:25AM  Neovasc (NVCN) Catches Eye: Stock Adds 27.1% in Session Zacks -7.30%
Mar-14-17 07:00AM  Neovasc to Host Fourth Quarter and Fiscal Year 2016 Conference Call PR Newswire +27.14%
Mar-10-17 07:00AM  Neovasc Announces TSX Symbol Change to NVCN PR Newswire
07:00AM  Neovasc Announces TSX Symbol Change to NVCN CNW Group
Feb-15-17 07:00AM  Neovasc to Present at the Leerink Partners Global Healthcare Conference PR Newswire
07:00AM  Neovasc to Present at the Leerink Partners Global Healthcare Conference CNW Group
Jan-18-17 02:04PM  Neovasc Announces Update in Litigation with CardiAQ PR Newswire -5.43%
Dec-23-16 12:28PM  Neovasc Announces Update in Litigation with CardiAQ PR Newswire +17.07%
Dec-19-16 01:56PM  Neovasc Regains Compliance with NASDAQ Listing Requirements PR Newswire -7.89%
Dec-15-16 08:00AM  BSX Investment Allows Neovasc to Continue Tiara Development Accesswire
Dec-14-16 08:24AM  Boston Scientific Acquires Neovasc to Boost Heart Business -9.48%
Dec-13-16 07:00AM  Neovasc and Boston Scientific Close US$75 Million Agreement PR Newswire
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets cardiovascular devices worldwide. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company also provides Peripatch tissue products. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.